WELLS FARGO & COMPANY/MN - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 88 filers reported holding DESIGN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,956
-75.9%
8,032
-35.6%
0.00%
Q2 2023$78,517
+127.0%
12,463
+107.9%
0.00%
Q1 2023$34,585
+394.1%
5,994
+1376.4%
0.00%
Q3 2022$7,000
+16.7%
406
-6.9%
0.00%
Q2 2022$6,000
-40.0%
436
-33.2%
0.00%
Q1 2022$10,000
-95.3%
653
-93.4%
0.00%
Q4 2021$213,0009,9430.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders